Beyond Single-Gene Testing: Using Polygenic Risk to Guide Precision Treatment
Wednesday, January 27, 2027 at 4:30 PM to 5:00 PM · 30 min. (Europe/London)
Pharmacogenomics & Patient Stratification Stage
Day 1 - Wednesday 27th January
Pharmacogenomics
Information
- Moving beyond traditional single-gene pharmacogenetics towards broader pharmacogenomic approaches.
- Exploring how an individual's overall genetic profile could help identify who is more or less likely to benefit from particular treatments or preventive interventions.
- Examples from diabetes and hypertension, including the use of polygenic risk to identify people who may benefit most from specific therapies.
- How population-scale genomic research can identify individuals at increased future disease risk and potentially enable more targeted prevention and treatment.
- The potential for integrating polygenic risk into healthcare systems to support more personalised treatment decisions.
- What evidence, validation and infrastructure are needed to move polygenic approaches from research into clinically useful pharmacogenomic tools.
